Innovative Patent Application to Enhance Virus Vector Production Using Ergothioneine Regeneosome, Good Hero Therapeutics, and Euglena have partnered to enhance virus vector production through a patented method utilizing ergothioneine. This technology targets the significant manufacturing challenges in gene therapy.

Innovative Patent Application to Enhance Virus Vector Production Using Ergothioneine #Japan #Minato-ku,_Tokyo #Regeneosome #Good_Hero #Euglena